Related Experiment Video
Updated: Jun 12, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Microtubule depolymerization potentiates alpha-synuclein oligomerization
A Raquel Esteves1, Daniela M Arduíno, Russell H Swerdlow
1Centro de Neurociências e Biologia Celular, Universidade de Coimbra Portugal.
Abstract:
Parkinson's disease (PD) is associated with perturbed mitochondria function and alpha-synuclein fibrillization. We evaluated potential mechanistic links between mitochondrial dysfunction and alpha-synuclein aggregation. We studied a PD cytoplasmic hybrid (cybrid) cell line in which platelet mitochondria from a PD subject were transferred to NT2 neuronal cells previously depleted of endogenous mitochondrial DNA. Compared to a control cybrid cell line, the PD line showed reduced ATP levels, an increased free/polymerized tubulin ratio, and alpha-synuclein oligomer accumulation. Taxol (which stabilizes microtubules) normalized the PD tubulin ratio and reduced alpha-synuclein oligomerization. A nexus exists between mitochondrial function, cytoskeleton homeostasis, and alpha-synuclein oligomerization. In our model, mitochondrial dysfunction triggers an increased free tubulin, which destabilizes the microtubular network and promotes alpha-synuclein oligomerization.
Insights
Mitochondrial dysfunction in Parkinson's disease (PD) may disrupt the cell's internal structure, promoting toxic alpha-synuclein clumps. Stabilizing microtubules with Taxol offers a potential therapeutic avenue for PD.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Parkinson's disease (PD) is characterized by mitochondrial dysfunction and alpha-synuclein aggregation.
- The interplay between these pathological hallmarks remains incompletely understood.
- Cytoskeletal integrity is crucial for neuronal function.
Purpose of the Study:
- To investigate the mechanistic link between mitochondrial dysfunction and alpha-synuclein aggregation in a cellular model of Parkinson's disease.
- To explore the role of the microtubule cytoskeleton in this process.
Main Methods:
- Utilized a Parkinson's disease (PD) cytoplasmic hybrid (cybrid) cell line with patient-derived mitochondria.
- Assessed cellular energetics (ATP levels), microtubule dynamics (tubulin ratio), and alpha-synuclein oligomerization.
- Administered Taxol, a microtubule-stabilizing agent, to PD cybrid cells.
Main Results:
- PD cybrid cells exhibited reduced ATP levels, increased free/polymerized tubulin ratio, and accumulated alpha-synuclein oligomers compared to controls.
- Taxol treatment normalized the tubulin ratio and decreased alpha-synuclein oligomerization in PD cybrid cells.
- These findings suggest mitochondrial dysfunction initiates cytoskeletal destabilization, promoting alpha-synuclein aggregation.
Conclusions:
- A significant nexus exists between mitochondrial function, cytoskeleton homeostasis, and alpha-synuclein oligomerization in Parkinson's disease.
- Mitochondrial dysfunction appears to trigger microtubule destabilization, which in turn promotes alpha-synuclein oligomerization.
- Targeting microtubule dynamics may represent a novel therapeutic strategy for Parkinson's disease.
More Related Videos
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
07:21Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
Published on: November 17, 2023
Related Concept Videos
Destabilization of Microtubules
Drugs that Stabilize Microtubules
Microtubule Associated Proteins (MAPs)
Drugs that Destabilize Microtubules
Assembly of Complex Microtubule Structures
Microtubule Instability